Medtronic Stock Hits Day High with Strong 4.06% Intraday Surge

Medtronic Plc has experienced a notable uptick in its stock performance, gaining 4.06% on August 10, 2026. The stock reached an intraday high of USD 89.45, reflecting a strong day for the company within the Pharmaceuticals & Biotechnology sector. In terms of performance metrics, Medtronic's one-day performance of 2.58% outpaced the S&P 500, which saw a slight decline of 0.06%. Over the past week, Medtronic has shown a 3.15% increase, while its one-month performance stands at 6.61%, again surpassing the S&P 500's 2.35% gain. However, the stock has faced challenges over the longer term, with a one-year performance of -3.74% compared to the S&P 500's impressive 21.34% return. The company maintains a low debt-to-equity ratio of 0.40, indicating a solid financial foundation. Additionally, Medtronic boasts a high institutional ownership of 86.93%, suggesting confidence from larger investors in the company's fundamentals. With a market capitalization of USD 111,878 million, Medtronic continues to be a significant player in its industry.